Acura Pharmaceuticals, Inc. (ACUR)

Acura Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	0	0	-1.08	-1.66	-3.95	-3.84
Depreciation & Amortization	0	0	0.09	0.13	0.27	0.28
Share-Based Compensation	0	0	0.06	0.04	0.11	0
Other Operating Activities	-	-	0.19	0.78	2.95	-0.35
Operating Cash Flow	0	0	-0.74	-0.72	-0.62	-3.91
Common Stock Issued	0	0	0	0	0.01	0
Share Repurchases	0	0	-0	-0	0	0
Other Financing Activities	-	-	0.39	0.27	1.38	1.78
Financing Cash Flow	0	0	0.39	0.27	1.39	1.78
Net Cash Flow	0	0	-0.35	-0.45	0.77	-2.13
Free Cash Flow	0	0	-0.74	-0.72	-0.62	-3.91
Free Cash Flow Margin	-	-	-47.47%	-20.14%	-23.26%	-953.17%
Free Cash Flow Per Share	-	-	-0.01	-0.02	-0.02	-0.18

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.